TICKERNERD
Menu
HITHITTechnology · Software - Application

HIT Stock Forecast: Health In Tech, Inc. Price Predictions for 2026-2027

Last close, 6 Oct 2026
$0.81
−1.23% on the day

The 2 Wall Street analysts covering Health In Tech, Inc. hold a median 12-month price target of $4 — +393.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 11 of 100 as at 6 Oct 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$53.0M
Ticker Nerd rank
11 / 100
Median analyst target
$4.00
Analysts covering
2
Revenue$8.1M−13.5% y/y
Operating income−$3.4M
Net income−$2.5M
Free cash flow−$3.5M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−5.1%
1M
−17.4%
YTD
−49.1%
1Y
−78.5%
From 52W high
−78.5%
From 52W low
+9.7%
$0.74
$3.77
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

HIT stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Health In Tech, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 6 Oct 2026
11 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
81
Issuance
45
Quality
39
Revisions
30
Growth
28
Value
23
Volatility
15
Accruals
15
Momentum
5

Size (81): Smaller than most of the companies we track.

Momentum (5): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

HIT stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on HIT, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$1.00$2.00$3.00$4.00Jan 26Apr 26Jul 26Oct 26HITHigh $4.10Median $4.00Low $1.25

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says2 analysts
2 Buy0 Hold0 Sell
Low $1.25Median $4.00High $4.10

The green dot is the last close — the median target sits +393.9% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
14 Aug 2026Maxim GroupMaintainsBuy$4.00 → $3.00
20 Apr 2026Craig-HallumInitiatesBuy$4.00
20 Apr 2026Craig-HallumInitiatesBuy—
26 June 2025Maxim GroupInitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HIT appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

HIT vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 6 Oct 2026, Health In Tech, Inc. returned −78.5% against +17.3% for the S&P 500, dividends included.

HIT vs S&P 500, last 12 monthsTotal return, rebased to 100
20406080100120Jan 26Apr 26Jul 26Oct 26HITS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

HIT analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
0
Analysts cutting
2
Fundamentals

Health In Tech, Inc. (HIT) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
76.0×

Cheaper than 9% of US stocks

Price / sales
1.6×

Cheaper than 58% of US stocks

Price / book
2.7×

Cheaper than 35% of US stocks

EV / EBITDA
18.2×

Cheaper than 18% of US stocks

Growth & margins
Revenue growth (YoY)
−13.5%

Higher than 14% of US stocks

Earnings growth (YoY)
−13.5%

Higher than 24% of US stocks

Gross margin
48.7%

Higher than 60% of US stocks

Operating margin
−42.7%

Higher than 18% of US stocks

Net margin
−12.0%

Higher than 19% of US stocks

Returns & dividend
Return on equity
−21.9%

Higher than 31% of US stocks

Return on assets
−12.7%

Higher than 24% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Health In Tech, Inc. (HIT) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Health In Tech, Inc. has a market value of $53.0M and an enterprise value of $46.7M.

  • Revenue in the twelve months to 30 June 2026: $32.8M. The latest quarter shrank 13.5% year on year.

  • Net income over the same four quarters: −$3.9M, a −12.0% net margin.

  • Diluted earnings per share, trailing twelve months: $−0.07.

  • Free cash flow in the twelve months to 30 June 2026: −$7.6M.

  • Shares outstanding: 65.6M.

  • Trailing P/E: 76.0×; forward P/E: −40.5× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Health In Tech, Inc. employs 87 people — $377K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 7 Oct 2026

Data provided by Twelve Data

Peers

HIT vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSoftware - Application
CompanyMarket capTKN rank
HITHealth In Tech, Inc.$53.0M
11
THRYThryv Holdings, Inc.$60.1M
82
IDNIntellicheck, Inc.$46.8M
71
ADBTAdvasa Holdings, Inc.$60.9M
1
CRGOFreightos Ltd.$44.6M
48
SCORcomScore, Inc.$63.5M
62
REKRRekor Systems, Inc.$44.2M
62

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Health In Tech, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest HIT news & analysis

Health In Tech to Attend the 17th Annual Craig-Hallum Alpha Select Conference

PRNewsWire · 2 Oct 2026neutral

Health In Tech, Inc. (Nasdaq: HIT) announced that representatives from its management and investor relations teams will attend the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026, at the Sheraton New York Times Square Hotel in New York City.

Why it matters — The conference participation provides HIT with an opportunity to present its AI-enabled InsurTech platform to investors and industry participants.

Health In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance

PRNewsWire · 30 Sept 2026positive

Health In Tech, Inc. announced the launch of HitRix, an AI-powered platform designed to modernize the U.S. self-funded health insurance market by streamlining large-group submissions, multi-market quoting, proposal comparison, and placement in a secure environment. The company also announced updated full-year 2026 revenue guidance.

Why it matters — A HIT watcher would care because the new HitRix platform expands the company's product offerings into the large self-funded insurance market while the updated 2026 revenue guidance signals a change in the company's forward outlook.

Health In Tech Named to Newsweek's America's Greatest Mid-Market Companies 2026

PRNewsWire · 9 Sept 2026positive

Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, announced it has been named to Newsweek's America's Greatest Mid-Market Companies 2026. The recognition followed an initial review of approximately 4,300 companies, with HIT among the 100 highest-scoring U.S. public mid-market companies based on financial strength, workforce performance, innovation and sustainability.

Why it matters — This award offers external validation of HIT's financial strength, workforce performance, innovation and sustainability, which could raise the company's visibility among investors and customers.

Health In Tech, Inc. (HIT) Q2 2026 Earnings Call Transcript

Seeking Alpha · 14 Aug 2026neutral

Health In Tech, Inc. (HIT) held its Q2 2026 earnings call, and Seeking Alpha published the full transcript of the call. The transcript documents the company's second-quarter fiscal 2026 results and related management discussion.

Why it matters — A HIT watcher would note the earnings call transcript as a primary source of the company's latest quarterly financial performance and management commentary.

Health In Tech Q2 Earnings Call Highlights

MarketBeat · 14 Aug 2026neutral

Health In Tech reported second-quarter revenue of $8.1 million, down 13.5% from $9.3 million a year earlier, attributing the decline to a new carrier onboarding that pushed certain policy effective dates to later quarters.

Why it matters — The revenue decline reflects timing shifts from carrier onboarding rather than underlying business deterioration, making it a key factor to watch as those deferred policies are expected to contribute in future quarters.

FAQ

Frequently asked questions about HIT stock

What is the HIT stock price forecast for 2026-2027?

The 2 Wall Street analysts covering Health In Tech, Inc. have a median 12-month price target of $4, with estimates ranging from $1.25 to $4.1. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is HIT stock a buy right now?

Of the 2 analysts covering Health In Tech, Inc., 2 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Health In Tech, Inc. 11 out of 100 across roughly 4,600 US stocks as at 6 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank HIT?

As at 6 Oct 2026, Health In Tech, Inc. ranks 11 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (81 of 100).

Will HIT stock go up?

No one can know that. What the data says: the median 12-month target from 2 analysts implies +393.9% from the last close, and Ticker Nerd's factor model ranks Health In Tech, Inc. 11 out of 100 as at 6 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the HIT stock forecast for 2030?

No analyst covering Health In Tech, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HIT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $1.25 to $4.1 over the next 12 months.

How has HIT stock performed over the past year?

Health In Tech, Inc. returned -78.5% over the 12 months to 6 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Health In Tech, Inc. do?

Health In Tech Inc. Class A Common Stock represents the public equity of Health In Tech Inc., an insurance technology platform company focused on the healthcare and insurance ecosystem.

What is the latest news on HIT?

The most recent item we track (PRNewsWire, 2 Oct 2026): "Health In Tech to Attend the 17th Annual Craig-Hallum Alpha Select Conference". Health In Tech, Inc. (Nasdaq: HIT) announced that representatives from its management and investor relations teams will attend the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026, at the Sheraton New York Times Square Hotel in New York City.

Company

About Health In Tech, Inc.

Health In Tech Inc. Class A Common Stock represents the public equity of Health In Tech Inc., an insurance technology platform company focused on the healthcare and insurance ecosystem. Health In Tech provides a marketplace designed to simplify underwriting, sales, and service workflows through vertical integration, process automation, and AI-enabled tools. Its current offerings include group insurance captives, community health plans, association health programs, self-funded benefits administration, stop-loss underwriting support, web-based quoting software, and services that help manage medical records, claims, and provider network pricing. The company serves small and medium-sized employers, licensed brokers, insurance companies, and third-party administrators, positioning itself as a technology layer that streamlines core insurance operations. Health In Tech Inc. is headquartered in Stuart, Florida.

CEO Mr. Tim Johnson · 87 employees · United States · https://healthintech.com